NEW YORK, Nov. 2 (GenomeWeb News) - Tecan and Dynal Biotech will co-develop and market optimized applications for separating, isolating, and manipulating biological material such as DNA, RNA, and proteins.
Under the terms of the non-exclusive agreement, which was originally announced on Oct. 15, the companies will develop applications using Dynal's Dynabeads magnetic bead kits and Tecan's Freedom EVO automated platform. Specific applications will include nucleic-acid extraction and preparation; PCR and sequencing clean-up procedures; and isolating recombinant proteins.
Financial details of the agreement were not disclosed.